Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08QJD
|
|||
| Former ID |
DIB000723
|
|||
| Drug Name |
IGN-311
|
|||
| Synonyms |
HuABL-364; IGN-314; Anti-Lewis Y mAb (cancer), Igeneon
Click to Show/Hide
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Terminated | [1] | |
| Company |
PDL BioPharma Inc
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Carbohydrate antigen Lewis-Y (Lewis-Y) | Target Info | . | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800006823) | |||
| REF 2 | IGN-311. Igeneon. Curr Opin Investig Drugs. 2005 Dec;6(12):1272-9. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.